| Literature DB >> 34970300 |
Dijana Majstorović1, Anita Barišić2, Mauro Štifanić3, Igor Dobrača1, Jadranka Vraneković2.
Abstract
Genetic discoveries and technological advances have been changing nursing care delivery, which modifies the roles and practices of nursing in society. Although the need for education of nurses in the field of genomics has been recognized in the 1960s, many countries still have no clear guidelines in this field of education and training. The purpose of this study was to evaluate current genomics content in the curriculum of undergraduate and graduate programs of studies in nursing in Croatia, and to measure the genomic literacy of Croatian undergraduate nursing students through assessing participants' understanding of genomic concepts most critical to nursing practice. The curriculum of undergraduate and graduate programs of nursing classes of 2020/2021 were independently analyzed by the authors. For measuring the knowledge of essential genomic concepts among nurses, a Genomic Nursing Concept Inventory (GNCI©) instrument was employed. Results indicate that the current genomics content, for undergraduate and graduate nursing programs in Croatia, is inadequate and not concordant among universities. Moreover, the genomic literacy of Croatian undergraduate students (Undergraduate program 10) was found to be low. Scores across respondents ranged from 3 to 22 (out of possible 31), with a mean scale score 9.8 (SD 5.3) (31.6% correct). We can conclude that the curriculum for undergraduate and graduate programs of Studies in nursing should be revised to implement the latest genomic practices and approaches to genomics education while nurses should acquire an adequate level of genomic literacy in order to produce desired outcomes of competency in nursing practice.Entities:
Keywords: curriculum; education; genomics; literacy; nursing
Year: 2021 PMID: 34970300 PMCID: PMC8712715 DOI: 10.3389/fgene.2021.759950
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Characteristics of the participants (n = 53).
| Variable | N (%) |
|---|---|
| Gender | |
| Male | 6 (11.3) |
| Female | 47 (88.7) |
| Employment | |
| Yes | 10 (18.9) |
| No | 43 (81.1) |
| Number of years in nursing | |
| 0 | 43 (81.1) |
| 1–5 | 4 (7.5) |
| 6–10 | 3 (5.7) |
| >10 | 3 (5.7) |
| Acquired knowledge about genomics through | |
| Literature on genomic topics | 24 (45.3) |
| Previous genomic course | 3 (5.7) |
| Previous genomic workshop | 1 (1.9) |
| Other resources | 27 (50.9) |
| Curricular progression | |
| 1st year | 39 (73.6) |
| 2nd year | 8 (15.1) |
| 3rd year | 6 (11.3) |
Curriculum for Undergraduate studies in nursing (academic year 2020/2021) in Croatia.
| University | Enrollment quota | Courses | ||||||
|---|---|---|---|---|---|---|---|---|
| Full–time study program | Part–time study program | Compulsory | Additional | Genomics included as | ||||
| Compulsory | Elective | Part of subject* | Independent subject | |||||
| 1 | Undergraduate program 1 | 95 | 30 | 48 | 1 | 23 | + | - |
| 2 | Undergraduate program 2 | 30 | 80 | 54 | 7 | 42 | + | - |
| 3 | Undergraduate program 3 | 30 | 120 | 48 | 2 | 16 | + | - |
| 4 | Undergraduate program 4 | 30 | 0 | 58 | 12 | 8 | + | - |
| 5 | Undergraduate program 5 | 0 | 21 | 49 | 2 | 18 | + | + |
| 6 | Undergraduate program 6 | 42 | 60 | 47 | 0 | 25 | + | - |
| 7 | Undergraduate program 7 | 41 | 20 | 50 | 3 | 10 | + | - |
| 8 | Undergraduate program 8 | 47 | 0 | 51 | 4 | 9 | + | - |
| 9 | Undergraduate program 9 | 33 | 117 | 47 | 0 | 31 | + | - |
| 10 | Undergraduate program 10 | 73 | 30 | 47 | 0 | 9 | + | + |
| Total | 421 | 478 | 499 | 31 | 191 | |||
*No defined learning outcomes and a number of hours related to genetic content.
Curriculum for Graduate studies in nursing (academic year 2020/2021) in Croatia.
| University | Enrollment quota | Courses | |||||
|---|---|---|---|---|---|---|---|
| Full–time study program | Part–time study program | Compulsory | Elective | Genomics included as | |||
| Part of subject* | Independent subject | ||||||
| 1 | Graduate program 1 | 0 | 20 | 110 | 60 | + | - |
| 2 | Graduate program 2 | 0 | 40 | 50 | 57 | + | - |
| 3 | Graduate program 3 | 30 | 150 | 13 | 10 | + | - |
| 4 | Graduate program 4 | 0 | 20 | 25 | 5 | - | - |
| 5 | Graduate program 5* | 0 | 0 | 32 | 11 | + | + |
| 6 | Graduate program 6 | 28 | 46 | 16 | 19 | - | - |
| 7 | Graduate program 7 | 15 | 15 | 15 | 18 | - | - |
| 8 | Graduate program 8 | 20 | 70 | 20 | 13 | + | + |
| 9 | Graduate program 9 | 20 | 30 | 9 | 13 | - | - |
| Total | 113 | 391 | 290 | 206 | |||
*No defined learning outcomes and a number of hours related to genetic content; **academic year 2020/2021 not enrolled.
GNCI© item scores, topical category scores and total score.
| Topical category | Domain | Item | Concept | Number of correct answers (%) |
|---|---|---|---|---|
| Genome Basics | Genome composition/ organization | 2 | DNA sequence = the order of nucleotides | 37 (69.8) |
| 4 | All cells contain an entire set of genes | 5 (9.4) | ||
| 5 | Genome organization (amount of DNA in the human genome) | 21 (39.6) | ||
| 8 | Organization of DNA (genome-chromosome-gene nucleotide) | 6 (11.3) | ||
| Homo and heterozygosity | 13 | Heterozygosity = two functionally different gene alleles | 4 (7.5) | |
| 29 | People with AD diseases are usually heterozygous for the mutation | 15 (28.3) | ||
| Gene function/ expression | 1 | Gene function/expression | 7 (13.2) | |
| 6 | Central dogma (product of DNA transcription-translation = protein) | 9 (17.0) | ||
| 9 | Specific role of a gene in determining a trait (produces a protein) | 10 (18.9) | ||
| 11 | Nature of gene expression (distinct from gene sequence) | 13 (24.5) | ||
| Genotype-phenotype association | 7 | Meaning of ‘genotype’ (distinguished from phenotype) | 15 (28.3) | |
| Human genome variation | 3 | >99% of DNA sequence of unrelated people is identical | 8 (15.1) | |
| 20 | All people have the same set of genes (e.g., BRCA) | 11 (20.8) | ||
|
|
| |||
| Mutations | Mutations and disease | 19 | Genetic heterogeneity (people with the same genetic condition may have unique mutations) | 14 (26.4) |
| 21 | DNA alterations cause disease by altering protein production | 15 (28.3) | ||
| Germline and somatic mutations | 18 | Distinguishing germline and somatic mutations | 2 (3.8) | |
|
|
| |||
| Inheritance | Dominance | 10 | The meaning of dominance | 13 (24.5) |
| Autosomal inheritance | 24 | Autosomal disorders are inherited equally by males and females | 14 (26.4) | |
| Autosomal dominant inheritance | 30 | Calculating inheritance risk in AD disease | 23 (43.4) | |
| 31 | Inheritance risk is fixed and independent of number of offspring | 20 (37.7) | ||
| Autosomal recessive inheritance | 15 | Parents of offspring with AR conditions are obligate carriers | 14 (26.4) | |
| 16 | Calculating inheritance risk in AR disease | 25 (47.2) | ||
| X-linked inheritance | 17 | Understanding inheritance of X-linked disorders | 20 (37.7) | |
| Multifactorial inheritance | 25 | Multifactorial etiology of complex diseases | 12 (22.6) | |
|
|
| |||
| Genomic healthcare | Family health history | 23 | Identifying red flags (risk factors) | 10 (18.9) |
| 26 | Utility of family history to predict risk for complex disease | 17 (32.1) | ||
| Pharmacogenomics | 12 | Mutations can cause people to respond unpredictably to drugs | 34 (64.2) | |
| 27 | A drug receptor is a protein (genetics and pharmacodynamics) | 15 (28.3) | ||
| 28 | Genes influence drug response via their effect on proteins | 11 (20.8) | ||
| Genetic testing | 14 | Meaning of a positive screening test | 27 (50.9) | |
| 22 | Purpose of carrier testing | 8 (15.1) | ||
|
|
| |||
|
|
| |||